Sitagliptin treatment in patients with type 2 diabetes mellitus after kidney transplant.
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 19 Jan 2010
At a glance
- Drugs Sitagliptin (Primary) ; Sirolimus; Tacrolimus
- Indications Renal transplant rejection; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 19 Jan 2010 Planned end date changed from 1 Dec 2008 to 1 Mar 2010 as reported by ClinicalTrials.gov.
- 19 Jan 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 10 May 2007 New trial record.